Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from SciELO through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Heterologous fibrin sealant derived from snake venom: from bench to bedside – an overview

Full text
Author(s):
Rui Seabra Ferreira Jr ; Luciana Curtolo de Barros [2] ; Luciana Patrícia Fernandes Abbade [3] ; Silvia Regina Catharino Sartori Barraviera [4] ; Maria Regina Cavariani Silvares [5] ; Leticia Gomes de Pontes ; Lucilene Delazari dos Santos ; Benedito Barraviera
Total Authors: 8
Document type: Journal article
Source: Journal of Venomous Animals and Toxins including Tropical Diseases; v. 23, 2017-07-06.
Abstract

Abstract Hemostatic and adhesive agents date back to World War II, when homologous fibrin sealant came onto scene. Considering that infectious diseases can be transmitted via human blood, a new heterologous fibrin sealant was standardized in the 1990s. Its components were a serine protease (a thrombin-like enzyme) extracted from the venom of Crotalus durissus terrificus snakes and a fibrinogen-rich cryoprecipitate extracted from the blood of Bubalus bubalis buffaloes. This new bioproduct has been used as a coagulant, sealant, adhesive and recently as a candidate scaffold for mesenchymal stem cells and bone and cartilage repair. This review discusses the composition of a new heterologous fibrin sealant, and cites published articles related to its preclinical applications aiming at repairing nervous system traumas and regenerating bone marrow. Finally, we present an innovative safety trial I/II that found the product to be a safe and clinically promising candidate for treating chronic venous ulcers. A multicenter clinical trial, phase II/III, with a larger number of participants will be performed to prove the efficacy of an innovative biopharmaceutical product derived from animal venom. (AU)

FAPESP's process: 09/53846-9 - Recent acquisition of preparative high-performance liquid chromatograph for the purification and isolation of serine proteinases to produce fibrin sealant
Grantee:Benedito Barraviera
Support Opportunities: Multi-user Equipment Program
FAPESP's process: 12/08101-8 - In vivo imaging of nerve regeneration following ventral root replantation with fluo-stained fibrin sealant associated with mesenchymal stem cells
Grantee:Rui Seabra Ferreira Junior
Support Opportunities: Regular Research Grants
FAPESP's process: 14/13299-7 - Identification of prognostic and diagnostics molecular biomarkers of cicatrization in the inflammatory exudate of chronic venous ulcers before and after treatment with fibrin sealant
Grantee:Lucilene Delazari dos Santos
Support Opportunities: Regular Research Grants